In today’s circumstances of the pharmaceutical industry, where profitability has decreased and competition has increased, the definition of business development activities expected to bring profit just in the middle and long term has completely changed to activities expected to bring results in the short term. Considering this change, today, business development is not just proposing a moleculebut at the same time a discipline covering converting this molecule into a product as soon as possible and questioning how, where and with what cost these products will be produced.
As CT Pharma, we continuously monitor the market, closely watch the progress and carry out the following project-based activities forthe purpose of enriching the portfolios of domestic and foreign pharmaceutical companies.
- review of current pipeline
- evaluation of current production and developmental potentials
- development of alternative molecules.